Study of Tocilizumab to Treat Polymyalgia Rheumatica

NCT01396317 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Polymyalgia Rheumatica (PMR)

Interventions

DRUG: Tocilizumab

Sponsor

Hospital for Special Surgery, New York

Collaborators

[object Object]